SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Chemical Name: 3-[(2-Cyano-3-ethoxy-3-oxo-1-propen-1-yl)amino]-1H-pyrazole-4-carboxylic Acid Ethyl Ester
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Smiles: O=C(C1=CNN=C1N/C=C(C#N)/C(OCC)=O)OCC
Allopurinol USP Related Compound F is chemically 3-[(2-Cyano-3-ethoxy-3-oxo-1-propen-1-yl)amino]-1H-pyrazole-4-carboxylic Acid Ethyl Ester. Allopurinol USP Related Compound F is supplied with detailed characterization data compliant with regulatory guideline. Allopurinol USP Related Compound F can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Allopurinol.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Automated fluorimetric determination of the genotoxic impurity hydrazine in allopurinol pharmaceuticals using zone fluidics and on-line solid phase extraction
Paraskevas D. Tzanavaras a,∗, Stefanos Themistokleous a, Constantinos K. Zacharis
Journal of Pharmaceutical and Biomedical Analysis 177 (2020) 112887
A Validated Stability Indicating RP-UPLC Method for the Quantitative Determination of Potential Impurities of Allopurinol
Sajan PG*1, Rohith T1, Santosh Patil2, Mantelingu K3, Rangappa K S3, Kumara M N
Am. J. Pharm Health Res 2014;2(10)
Development Of A Stability Indicating RP-RRLC Method For Determination Of Allopurinol And Its Degradation Products In Solid Oral Dosage
Sukhdev Singh1*, Zakir Gadhawala
Int.J.PharmTech Res.2013,5(1), pp 44-53